FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Magdolna Kovacs

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Procedures

Physiology

Gene Expression

Co-author Network

Publications

TOP 3
Ferenc Rick; Andrew V Schally; Luca Szalontay; Karoly Szepeshazi; Irving Vidaurre; Marta Zarandi; Norman Block; Magdolna Kovacs; Mehrdad Nadji; Zoltan Rekasi
Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.
Luca Szalontay; Irving Vidaurre; Marta Zarandi; Ronald Benveniste; Norman Block; Mehrdad Nadji; Andrew V Schally; Magdolna Kovacs
Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissue.
Petra Popovics; Zoltan Rekasi; Alan J Stewart; Magdolna Kovacs
Regulation of pituitary inhibin/activin subunits and follistatin gene expression by GnRH in female rats.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Magdolna Kovacs (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ferenc Rick; Andrew V Schally; Luca Szalontay; Karoly Szepeshazi; Irving Vidaurre; Marta Zarandi; Norman Block; Magdolna Kovacs; Mehrdad Nadji; Zoltan Rekasi
Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.
The Journal of urology 2012;187(4):1498-504.
2012: Luca Szalontay; Irving Vidaurre; Marta Zarandi; Ronald Benveniste; Norman Block; Mehrdad Nadji; Andrew V Schally; Magdolna Kovacs
Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissue.
Neuroendocrinology 2012;96(1):81-8.
2011: Petra Popovics; Zoltan Rekasi; Alan J Stewart; Magdolna Kovacs
Regulation of pituitary inhibin/activin subunits and follistatin gene expression by GnRH in female rats.
The Journal of endocrinology 2011;210(1):71-9.
2006: Marta Zarandi; Jozsef Varga; Andrew V Schally; Judit E Horvath; Gabor L Toller; Magdolna Kovacs; Markus Letsch; Kate Groot; Patricia Armatis; Gabor Halmos
Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activities.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(12):4610-5.
2004: Jozsef Varga; Andrew V Schally; Judit E Horvath; Magdolna Kovacs; Gabor Halmos; Kate Groot; Gabor L Toller; Zoltan Rekasi; Marta Zarandi
Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(6):1708-13.
2002: Judit E Horvath; Ana M Bajo; Andrew V Schally; Magdolna Kovacs; Francine Herbert; Kate Groot
Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(23):15048-53.
2002: Magdolna Kovacs; Andrew V Schally; E-J Lee; Rebeca Busto; Patricia Armatis; Kate Groot; Jozsef Varga
Inhibitory effects of antagonistic analogs of GHRH on GH3 pituitary cells overexpressing the human GHRH receptor.
The Journal of endocrinology 2002;175(2):425-34.
2002: Magdolna Kovacs; J Seprodi; Miklos Koppan; Judit E Horvath; Borbála Vincze; I Teplan; B Flerko
Lamprey gonadotropin hormone-releasing hormone-III has no selective follicle-stimulating hormone-releasing effect in rats.
Journal of neuroendocrinology 2002;14(8):647-55.
2002: Magdolna Kovacs; Andrew V Schally; Balazs Csernus; Rebeca Busto; Zoltan Rekasi; Attila Nagy
Targeted cytotoxic analogue of luteinizing hormone-releasing hormone (LH-RH) only transiently decreases the gene expression of pituitary receptors for LH-RH.
Journal of neuroendocrinology 2002;14(1):5-13.
2001: Magdolna Kovacs; Andrew V Schally
Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(21):12197-202.
2001: Andrew V Schally; Ana Maria Comaru-Schally; Attila Nagy; Magdolna Kovacs; Karoly Szepeshazi; Artur Plonowski; Jozsef Varga; Gabor Halmos
Hypothalamic hormones and cancer.
Frontiers in neuroendocrinology 2001;22(4):248-91.
2001: Magdolna Kovacs; Andrew V Schally; Balazs Csernus; Zoltan Rekasi
Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(4):1829-34.
2000: Magdolna Kovacs; Rhonda D Kineman; Andrew V Schally; B Flerko; Lawrence A Frohman
Increase in mRNA concentrations of pituitary receptors for growth hormone-releasing hormone and growth hormone secretagogues after neonatal monosodium glutamate treatment.
Journal of neuroendocrinology 2000;12(4):335-41.
1998: K Toth; Magdolna Kovacs; Marta Zarandi; Gabor Halmos; Kate Groot; Attila Nagy; Z Kele; Andrew V Schally
New analogs of human growth hormone-releasing hormone (1-29) with high and prolonged antagonistic activity.
The journal of peptide research : official journal of the American Peptide Society 1998;51(2):134-41.
1997: Magdolna Kovacs; Rhonda D Kineman; Andrew V Schally; Marta Zarandi; Kate Groot; Lawrence A Frohman
Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
Endocrinology 1997;138(11):4536-42.
1997: Magdolna Kovacs; Andrew V Schally; Attila Nagy; Miklos Koppan; Kate Groot
Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(4):1420-5.
1997: Marta Zarandi; Magdolna Kovacs; Judit E Horvath; K Toth; Gabor Halmos; Kate Groot; Attila Nagy; Z Kele; Andrew V Schally
Synthesis and in vitro evaluation of new potent antagonists of growth hormone-releasing hormone (GH-RH).
Peptides 1997;18(3):423-30.
1996: Magdolna Kovacs; Márta Zarándi; Gabor Halmos; Kate Groot; Andrew V Schally
Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
Endocrinology 1996;137(12):5364-9.
1996: Attila Nagy; Andrew V Schally; Patricia Armatis; Karoly Szepeshazi; Gabor Halmos; Magdolna Kovacs; Marta Zarandi; Kate Groot; M Miyazaki; Andreas Jungwirth; J Horvath
Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(14):7269-73.
1988: S Bajusz; Magdolna Kovacs; M Gazdag; L Bokser; T Karashima; V J Csernus; T Janaky; J Guoth; Andrew V Schally
Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(5):1637-41.
1988: Magdolna Kovacs; Jozsef Gulyas; S Bajusz; Andrew V Schally
An evaluation of intravenous, subcutaneous, and in vitro activity of new agmatine analogs of growth hormone-releasing hormone hGH-RH (1-29)NH2.
Life sciences 1988;42(1):27-35.
1987: J Guoth; D B Olsen; Magdolna Kovacs; Andrew V Schally
Synthesis, purification and biological evaluation of porcine corticotropin-releasing factor.
Life sciences 1987;41(8):1003-10.